EVONIK INDUSTRIES AG

Evonik Industries Q3 2026: €3.825bn revenue, €629m adjusted EBITDA up 40%, net loss halved, and management confident of upper‑half EBITDA forecast.

Explore how BASF’s interest in Evonik and booming probiotics & sodium silicate markets could reshape valuation and unlock value for investors.

Evonik Industries AG faces a fresh, €24‑per‑share takeover bid from BASF, amid mixed market reactions and a cautiously bullish outlook for the specialty‑chemicals firm.